Sartorius grows dynamically and profitably - Substantial double-digit increases in sales and earnings

Author's Avatar
Oct 20, 2021

- Order intake up 72.3 percent; sales revenue up 53.9 percent; underlying EBITDA margin 34.3 percent

- Both divisions with strong double-digit growth; significant demand momentum generated by the production of coronavirus vaccines and test kits as well as excellent development of acquisitions

- Forecast raised at the beginning of July for 2021 confirmed

PR Newswire